RON KURTZ
CEO/PRESIDENT
RXSIGHT
WHY: Oversees Aliso Viejo firm that commercialized the world’s first and only adjustable intraocular lens that is customized after cataract surgery.
IN THE NEWS: In April, the company introduced its newest lens, the LAL+, designed to extend the depth of focus. Revealed during a conference call that the company recently received approval from the FDA for a version of LAL+ with an expanded power range, which is expected to launch by the end of this year.
NOTABLE: Company in August reported that Q2 sales increased 68% to $34.9M.
QUOTABLE: “RxSight’s strong Q2 performance as well as our revised 2024 guidance is based on our technology’s ability to meet the clinical needs of patients and doctors as well as the business needs of practices.”
